Evidence map›Paper›PMID 41844578›Full record

ArticleCell death discovery2026

Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer.

Joana E Aggrey-Fynn, Joshua Busch, Dominik Saul, Ashish Rajput, Kerstin Willecke, Meghana Manjunath, Nicole Klimt, Kothai Rajendran, Nadine Schacherer, Wanwan Ge and 5 more

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joana E Aggrey-FynnRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Joshua BuschRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Dominik SaulRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Ashish RajputRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Kerstin WilleckeDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.
Meghana ManjunathRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Nicole KlimtDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.
Kothai RajendranRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.
Nadine SchachererRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.ORCID http://orcid.org/0000-0001-7738-854X
Wanwan GeRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.ORCID http://orcid.org/0000-0001-8879-077X
Julia ThielDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.ORCID http://orcid.org/0009-0003-5437-8498
Amro AbdelrahmanDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9865-0551
Mark J TrutyDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Meng DongDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.ORCID http://orcid.org/0000-0002-6434-1678
Steven A JohnsenRobert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany. steven.johnsen@uni-tuebingen.de.ORCID http://orcid.org/0000-0003-1198-5805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NF-κB signaling can be subdivided into canonical and noncanonical pathways, culminating in the transcriptional activity of RELA and RELB, respectively. However, the upstream signals that activate these transcription factors and their specific regulatory roles in pancreatic ductal adenocarcinoma (PDAC) remain incompletely understood. We investigated the differential activation and function of RELA and RELB in PDAC using transcriptome-wide gene expression profiling, genome-wide occupancy mapping, and epigenomic analysis. Temporal activation patterns were assessed following TNFα or TWEAK stimulation. Single-cell RNA sequencing and multiplex immunofluorescence staining were used to characterize activity in primary PDAC tissues. Motif enrichment and chromatin accessibility were evaluated to determine transcription factor binding dynamics and co-regulatory associations. We demonstrate that TNFα is the primary activator of canonical NF-κB signaling via RELA, while TWEAK selectively engages noncanonical signaling through RELB in PDAC. RELA and RELB display distinct temporal dynamics and regulatory activity. RELA binds to both open and closed chromatin and drives a broad transcriptional program, while RELB exclusively occupies pre-accessible chromatin regions co-enriched for AP1 motifs. Motif analysis reveals a particularly strong association of RELB with AP1 elements, suggesting selective co-regulation. Single-cell transcriptomic analysis and multiplex staining in primary tumors reveal distinct spatial and cellular distribution patterns, with RELA and RELB active in separate tumor and microenvironmental compartments. These findings underscore the distinct and complementary roles of TNFα and TWEAK in regulating NF-κB signaling in PDAC. TNFα engages a broader transcriptional program via RELA, whereas TWEAK targets a more selective set of genes marked by chromatin accessibility and AP1 co-binding through RELB. This study provides critical insight into the regulatory dynamics of NF-κB signaling in pancreatic cancer and highlights the specialized functions of RELA and RELB in modulating gene expression and tumor-microenvironment interactions.

Identifiers

PMID41844578
PMCPMC13039881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.